The DARE-19 trial explored repurposing existing medications to treat COVID-19.

Healio talked to Dr. Mikhail Kosiborod, Vice President of Research at Saint Luke's Health System and the Ben McCallister, MD, Endowed Chair in Cardiovascular Research at Saint Luke's Mid America Heart Institute, about the hypothesis that SGLT2 inhibitors can provide organ protection in acute illness beyond COVID-19.

Watch the full Healio interview: VIDEO: SGLT2 inhibitors may protect organs in acute illness

Read more

Related Content

Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

Read more
Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

Read more
Person, Hair, Nurse, Face, Female, Word
Nicole's story

"What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

Read more